New therapy combining gene transfer and enhanced enzyme delivery for treating Morquio A Syndrome in children
Morquio A therapy integrating gene transfer with lectin-enhanced enzyme delivery to treat multisystemic clinical impairments of rare metabolic childhood diseases
This study is testing a new treatment for kids with Morquio A Syndrome that uses a special method to deliver an important enzyme, hoping to help them feel better and improve their breathing, heart health, and movement.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biostrategies, Lc NIH-funded |
| Lab location | 1 site (State University, United States) |
| Project ID | NIH-10821924 on NIH RePORTER |
What this research studies
This research focuses on developing a novel therapy for Morquio A Syndrome, a rare genetic disorder in children that leads to severe health issues affecting multiple body systems. The approach integrates gene transfer with a unique enzyme delivery system using plant lectins to improve the effectiveness of treatment. By targeting the underlying enzyme deficiency, the therapy aims to reduce the harmful accumulation of specific substances in the body that cause debilitating symptoms. Patients will be monitored for improvements in their respiratory, cardiovascular, and musculoskeletal health as part of the treatment process.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with Morquio A Syndrome, particularly those aged 0-11 years.
Not a fit: Patients with other genetic disorders or those outside the age range of 0-11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life and health outcomes for children suffering from Morquio A Syndrome.
How similar studies have performed: Previous studies using similar enzyme delivery technologies have shown promising results in animal models, indicating potential for success in human applications.
Where this research is happening
State University, United States
- Biostrategies, Lc — State University, United States (Active)
Researchers
- Principal investigator: Acosta, Walter — Biostrategies, Lc
- Study coordinator: Acosta, Walter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.